Welcome to Blood Cancer United Newsroom
Get the latest news about how we are creating a world without blood cancers—and improving the quality of life of patients and their families.
Research
Kymera Therapeutics Presents Preclinical Data and Shares Profile of Clinical Candidate KT-253 at the AACR Annual Meeting 2022
WATERTOWN, Mass., April 08, 2022 - Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing targeted protein deg…
News
Royalty Pharma Announces Charitable Alliance with The Leukemia & Lymphoma Society (LLS) To Advance Initiatives that Address Healthcare Disparities in Blood Cancer Care and Treatment
Royalty Pharma plc (Nasdaq: RPRX) today announced a charitable commitment totaling $7.5 million to The Leukemia & Lymphoma Society (LLS), a global lea…
Research
CDP Achievement Awards 2021
Due to the ongoing pandemic, the winners of the third annual CDP Achievement Awards received their awards via mail, but we are looking forward to cong…
Professional Education Webcasts
Avoiding Roadblocks in Coordinating CAR-T Therapy for B-cell Lymphoma: Practical Tips for Community Oncology Clinicians
Part 3 of 4 in a series on: The Evolving Role of CAR T-cell Therapy for R/R B-cell Lymphomas: Improving Access and Outcomes
Patient Education Webcasts
Advances in Multiple Myeloma
News
The Leukemia & Lymphoma Society Earns a “Superior” Rating in New, Independent Analysis of Chronic Disease Nonprofits
In a new, independent analysis of chronic disease organizations by Cause Reports, The Leukemia & Lymphoma Society (LLS) received the highest score and…
Professional Education Webcasts
What You MUST Know As More Lymphoma Patients Are On The Road To CAR-T
Part 2 of 4 in a series on: The Evolving Role of CAR T-cell Therapy for R/R B-cell Lymphomas: Improving Access and Outcomes
For all media-related inquiries and interview requests please email
mediarelations@bloodcancerunited.org
A Blood Cancer United representative will respond as soon as possible.
